Who Owns Solid Biosciences Stock?
NASDAQ: SLDBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 106.08%
- Institutions (% of float)
- 106.79%
- Held by insiders
- 0.66%
- Institutional holders
- 214
- Institutions 99.3%
- Insiders 0.7%
- Public and other 0.0%
Who owns Solid Biosciences stock?
Institutional investors own about 106.1% of Solid Biosciences's shares, spread across 214 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.66% of SLDB.
The largest institutional holders are RA Capital Management, L.P. (10.78%), Perceptive Advisors Llc (10.67%) and Bain Capital Life Sciences Investors, LLC (8.79%). Together, the top 10 institutions control 66.4% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their SLDB positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SLDB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RA Capital Management, L.P. | 12.04M | 10.78% | 0.0% |
| Perceptive Advisors Llc | 11.91M | 10.67% | 0.0% |
| Bain Capital Life Sciences Investors, LLC | 9.81M | 8.79% | 0.0% |
| Siren, L.L.C. | 7.69M | 6.89% | 0.0% |
| FMR, LLC | 7.27M | 6.52% | +5.8% |
| Blackrock Inc. | 6.84M | 6.12% | -1.4% |
| RTW Investments LP | 5.91M | 5.29% | +51.7% |
| Armistice Capital, LLC | 4.50M | 4.03% | +5.1% |
| Franklin Templeton, Inc. | 4.19M | 3.76% | +21.9% |
| Vanguard Capital Management LLC | 3.97M | 3.56% | -1.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SLDB
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.15M | 2.82% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 2.61M | 2.34% |
| iShares Trust-iShares Russell 2000 ETF | 1.97M | 1.76% |
| Columbia Funds Series Trust I-Columbia Small Cap Growth Fund | 1.76M | 1.58% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.75M | 1.57% |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 1.41M | 1.26% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 864.55K | 0.77% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 774.01K | 0.69% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 677.57K | 0.61% |
| iShares Trust-iShares Biotechnology ETF | 669.09K | 0.60% |
Frequently asked questions
Who is the largest shareholder of Solid Biosciences?
RA Capital Management, L.P. is the largest institutional shareholder of SLDB, owning 10.78% of shares outstanding (12.04M shares) as of its latest 13F filing.
What percentage of Solid Biosciences is owned by institutions?
Institutions own about 106.1% of SLDB shares and 106.8% of the public float.
How much of Solid Biosciences do insiders own?
Insiders, such as officers and directors, own about 0.66% of SLDB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.